Endocrine-Related Cancer ( 2012 ) 19 L 15 – L 18 The effect of the ATG 16 L 1 Thr 300 Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma
暂无分享,去创建一个
L. Kiemeney | L. Joosten | M. Netea | J. Gudmundsson | K. Aben | R. Netea-Maier | T. Plantinga | A. Hermus
[1] M. Oosting,et al. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 , 2011, Gut.
[2] D. Jewell,et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.
[3] L. Duntas,et al. The ‘rings of fire’ and thyroid cancer , 2009, Hormones.
[4] Kari Stefansson,et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.
[5] Nathaniel Rothman,et al. International patterns and trends in thyroid cancer incidence, 1973–2002 , 2009, Cancer Causes & Control.
[6] S. Akira,et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.
[7] K. Aben,et al. Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: Correlation with thyroid fine‐needle aspiration cytology and thyroid surgery , 2008, International journal of cancer.
[8] E. Voronov,et al. Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. , 2002, Seminars in cancer biology.
[9] J. Hershman,et al. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. , 1996, The Journal of clinical endocrinology and metabolism.
[10] S. Nagataki,et al. Interleukin-1 inhibits human thyroid carcinoma cell growth. , 1992, The Journal of clinical endocrinology and metabolism.